Philip Morris Closes In On Vectura As £1.1bn Offer Passes Threshold
Takeover Steeped In Controversy, With Objections Raised By Healthcare Charities
Philip Morris once again pledged to up R&D in Vectura after its £1.1bn takeover offer for the UK-based inhalation specialist became unconditional, following the tobacco giant’s acrimonious face-off with private equity Carlyle earlier this year.